Selected research
Industry Research
Exosome Analytical Service Industry Research Report 2026
Market perspective
The global Exosome Analytical Service market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Exosome Analytical Service market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Exosome Analytical Service market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Exosome Analytical Service market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Exosome Analytical Service include Codiak Biosciences, Aethlon Medical, NanoSomix, Aruna Bio, Exosome Diagnostics, Beijing Enze Kangtai Biotechnology, System Biosciences, Qiagen and Norgen Biotek Corp., among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Exosome Analytical Service market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Exosome Analytical Service.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Exosome Analytical Service Market by Company
Codiak Biosciences
Aethlon Medical
NanoSomix
Aruna Bio
Exosome Diagnostics
Beijing Enze Kangtai Biotechnology
System Biosciences
Qiagen
Norgen Biotek Corp.
HansaBioMed Life Sciences
AMS Biotechnology
Sistemic Scotland
NanoView Biosciences
Malvern Panalytical
Evomic Science
BioIVT
Codiak Biosciences
Creative Biolabs
Evox Therapeutics
Precision NanoSystems
Unisensor SA
VolitionRx Limited
Capricor Therapeutics
Pure Biologics
Janssen Biotech
Exosome Analytical Service Segment by Type
Exosome Isolation and Purification
Exosome Quantification
Exosome Characterization
Exosome Cargo Analysis
Exosome Uptake and Signaling Analysis
Exosome Functional Studies
Exosome Analytical Service Segment by Application
Biopharmaceutical R&D
Clinical Medicine
Life Science Research
Agricultural Technology
Other
Exosome Analytical Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Exosome Analytical Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Exosome Analytical Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Exosome Analytical Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Exosome Analytical Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Exosome Isolation and Purification
- Exosome Quantification
- Exosome Characterization
- Exosome Cargo Analysis
- Exosome Uptake and Signaling Analysis
- Exosome Functional Studies
Applications
- Biopharmaceutical R&D
- Clinical Medicine
- Life Science Research
- Agricultural Technology
- Other
Companies covered
- Codiak Biosciences
- Aethlon Medical
- NanoSomix
- Aruna Bio
- Exosome Diagnostics
- Beijing Enze Kangtai Biotechnology
- System Biosciences
- Qiagen
- Norgen Biotek Corp.
- HansaBioMed Life Sciences
- AMS Biotechnology
- Sistemic Scotland
- NanoView Biosciences
- Malvern Panalytical
- Evomic Science
- BioIVT
- Codiak Biosciences
- Creative Biolabs
- Evox Therapeutics
- Precision NanoSystems
- Unisensor SA
- VolitionRx Limited
- Capricor Therapeutics
- Pure Biologics
- Janssen Biotech
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Exosome Analytical Service by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Exosome Isolation and Purification
- 2.2.3 Exosome Quantification
- 2.2.4 Exosome Characterization
- 2.2.5 Exosome Cargo Analysis
- 2.2.6 Exosome Uptake and Signaling Analysis
- 2.2.7 Exosome Functional Studies
- 2.3 Exosome Analytical Service by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Biopharmaceutical R&D
- 2.3.3 Clinical Medicine
- 2.3.4 Life Science Research
- 2.3.5 Agricultural Technology
- 2.3.6 Other
- 2.4 Assumptions and Limitations
3 Exosome Analytical Service Breakdown Data by Type
- 3.1 Global Exosome Analytical Service Historic Market Size by Type (2021-2026)
- 3.2 Global Exosome Analytical Service Forecasted Market Size by Type (2027-2032)
4 Exosome Analytical Service Breakdown Data by Application
- 4.1 Global Exosome Analytical Service Historic Market Size by Application (2021-2026)
- 4.2 Global Exosome Analytical Service Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Exosome Analytical Service Market Perspective (2021-2032)
- 5.2 Global Exosome Analytical Service Growth Trends by Region
- 5.2.1 Global Exosome Analytical Service Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Exosome Analytical Service Historic Market Size by Region (2021-2026)
- 5.2.3 Exosome Analytical Service Forecasted Market Size by Region (2027-2032)
- 5.3 Exosome Analytical Service Market Dynamics
- 5.3.1 Exosome Analytical Service Industry Trends
- 5.3.2 Exosome Analytical Service Market Drivers
- 5.3.3 Exosome Analytical Service Market Challenges
- 5.3.4 Exosome Analytical Service Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Exosome Analytical Service Players by Revenue
- 6.1.1 Global Top Exosome Analytical Service Players by Revenue (2021-2026)
- 6.1.2 Global Exosome Analytical Service Revenue Market Share by Players (2021-2026)
- 6.2 Global Exosome Analytical Service Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Exosome Analytical Service Head Office and Area Served
- 6.4 Global Exosome Analytical Service Players, Product Type & Application
- 6.5 Global Exosome Analytical Service Manufacturers Established Date
- 6.6 Global Exosome Analytical Service Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Exosome Analytical Service Market Size (2021-2032)
- 7.2 North America Exosome Analytical Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Exosome Analytical Service Market Size by Country (2021-2026)
- 7.4 North America Exosome Analytical Service Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Exosome Analytical Service Market Size (2021-2032)
- 8.2 Europe Exosome Analytical Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Exosome Analytical Service Market Size by Country (2021-2026)
- 8.4 Europe Exosome Analytical Service Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Exosome Analytical Service Market Size (2021-2032)
- 9.2 Asia-Pacific Exosome Analytical Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Exosome Analytical Service Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Exosome Analytical Service Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Exosome Analytical Service Market Size (2021-2032)
- 10.2 South America Exosome Analytical Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Exosome Analytical Service Market Size by Country (2021-2026)
- 10.4 South America Exosome Analytical Service Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Exosome Analytical Service Market Size (2021-2032)
- 11.2 Middle East & Africa Exosome Analytical Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Exosome Analytical Service Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Exosome Analytical Service Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Codiak Biosciences
- 12.1.1 Codiak Biosciences Company Information
- 12.1.2 Codiak Biosciences Business Overview
- 12.1.3 Codiak Biosciences Revenue in Exosome Analytical Service Business (2021-2026)
- 12.1.4 Codiak Biosciences Exosome Analytical Service Product Portfolio
- 12.1.5 Codiak Biosciences Recent Developments
- 12.2 Aethlon Medical
- 12.2.1 Aethlon Medical Company Information
- 12.2.2 Aethlon Medical Business Overview
- 12.2.3 Aethlon Medical Revenue in Exosome Analytical Service Business (2021-2026)
- 12.2.4 Aethlon Medical Exosome Analytical Service Product Portfolio
- 12.2.5 Aethlon Medical Recent Developments
- 12.3 NanoSomix
- 12.3.1 NanoSomix Company Information
- 12.3.2 NanoSomix Business Overview
- 12.3.3 NanoSomix Revenue in Exosome Analytical Service Business (2021-2026)
- 12.3.4 NanoSomix Exosome Analytical Service Product Portfolio
- 12.3.5 NanoSomix Recent Developments
- 12.4 Aruna Bio
- 12.4.1 Aruna Bio Company Information
- 12.4.2 Aruna Bio Business Overview
- 12.4.3 Aruna Bio Revenue in Exosome Analytical Service Business (2021-2026)
- 12.4.4 Aruna Bio Exosome Analytical Service Product Portfolio
- 12.4.5 Aruna Bio Recent Developments
- 12.5 Exosome Diagnostics
- 12.5.1 Exosome Diagnostics Company Information
- 12.5.2 Exosome Diagnostics Business Overview
- 12.5.3 Exosome Diagnostics Revenue in Exosome Analytical Service Business (2021-2026)
- 12.5.4 Exosome Diagnostics Exosome Analytical Service Product Portfolio
- 12.5.5 Exosome Diagnostics Recent Developments
- 12.6 Beijing Enze Kangtai Biotechnology
- 12.6.1 Beijing Enze Kangtai Biotechnology Company Information
- 12.6.2 Beijing Enze Kangtai Biotechnology Business Overview
- 12.6.3 Beijing Enze Kangtai Biotechnology Revenue in Exosome Analytical Service Business (2021-2026)
- 12.6.4 Beijing Enze Kangtai Biotechnology Exosome Analytical Service Product Portfolio
- 12.6.5 Beijing Enze Kangtai Biotechnology Recent Developments
- 12.7 System Biosciences
- 12.7.1 System Biosciences Company Information
- 12.7.2 System Biosciences Business Overview
- 12.7.3 System Biosciences Revenue in Exosome Analytical Service Business (2021-2026)
- 12.7.4 System Biosciences Exosome Analytical Service Product Portfolio
- 12.7.5 System Biosciences Recent Developments
- 12.8 Qiagen
- 12.8.1 Qiagen Company Information
- 12.8.2 Qiagen Business Overview
- 12.8.3 Qiagen Revenue in Exosome Analytical Service Business (2021-2026)
- 12.8.4 Qiagen Exosome Analytical Service Product Portfolio
- 12.8.5 Qiagen Recent Developments
- 12.9 Norgen Biotek Corp.
- 12.9.1 Norgen Biotek Corp. Company Information
- 12.9.2 Norgen Biotek Corp. Business Overview
- 12.9.3 Norgen Biotek Corp. Revenue in Exosome Analytical Service Business (2021-2026)
- 12.9.4 Norgen Biotek Corp. Exosome Analytical Service Product Portfolio
- 12.9.5 Norgen Biotek Corp. Recent Developments
- 12.10 HansaBioMed Life Sciences
- 12.10.1 HansaBioMed Life Sciences Company Information
- 12.10.2 HansaBioMed Life Sciences Business Overview
- 12.10.3 HansaBioMed Life Sciences Revenue in Exosome Analytical Service Business (2021-2026)
- 12.10.4 HansaBioMed Life Sciences Exosome Analytical Service Product Portfolio
- 12.10.5 HansaBioMed Life Sciences Recent Developments
- 12.11 AMS Biotechnology
- 12.11.1 AMS Biotechnology Company Information
- 12.11.2 AMS Biotechnology Business Overview
- 12.11.3 AMS Biotechnology Revenue in Exosome Analytical Service Business (2021-2026)
- 12.11.4 AMS Biotechnology Exosome Analytical Service Product Portfolio
- 12.11.5 AMS Biotechnology Recent Developments
- 12.12 Sistemic Scotland
- 12.12.1 Sistemic Scotland Company Information
- 12.12.2 Sistemic Scotland Business Overview
- 12.12.3 Sistemic Scotland Revenue in Exosome Analytical Service Business (2021-2026)
- 12.12.4 Sistemic Scotland Exosome Analytical Service Product Portfolio
- 12.12.5 Sistemic Scotland Recent Developments
- 12.13 NanoView Biosciences
- 12.13.1 NanoView Biosciences Company Information
- 12.13.2 NanoView Biosciences Business Overview
- 12.13.3 NanoView Biosciences Revenue in Exosome Analytical Service Business (2021-2026)
- 12.13.4 NanoView Biosciences Exosome Analytical Service Product Portfolio
- 12.13.5 NanoView Biosciences Recent Developments
- 12.14 Malvern Panalytical
- 12.14.1 Malvern Panalytical Company Information
- 12.14.2 Malvern Panalytical Business Overview
- 12.14.3 Malvern Panalytical Revenue in Exosome Analytical Service Business (2021-2026)
- 12.14.4 Malvern Panalytical Exosome Analytical Service Product Portfolio
- 12.14.5 Malvern Panalytical Recent Developments
- 12.15 Evomic Science
- 12.15.1 Evomic Science Company Information
- 12.15.2 Evomic Science Business Overview
- 12.15.3 Evomic Science Revenue in Exosome Analytical Service Business (2021-2026)
- 12.15.4 Evomic Science Exosome Analytical Service Product Portfolio
- 12.15.5 Evomic Science Recent Developments
- 12.16 BioIVT
- 12.16.1 BioIVT Company Information
- 12.16.2 BioIVT Business Overview
- 12.16.3 BioIVT Revenue in Exosome Analytical Service Business (2021-2026)
- 12.16.4 BioIVT Exosome Analytical Service Product Portfolio
- 12.16.5 BioIVT Recent Developments
- 12.17 Codiak Biosciences
- 12.17.1 Codiak Biosciences Company Information
- 12.17.2 Codiak Biosciences Business Overview
- 12.17.3 Codiak Biosciences Revenue in Exosome Analytical Service Business (2021-2026)
- 12.17.4 Codiak Biosciences Exosome Analytical Service Product Portfolio
- 12.17.5 Codiak Biosciences Recent Developments
- 12.18 Creative Biolabs
- 12.18.1 Creative Biolabs Company Information
- 12.18.2 Creative Biolabs Business Overview
- 12.18.3 Creative Biolabs Revenue in Exosome Analytical Service Business (2021-2026)
- 12.18.4 Creative Biolabs Exosome Analytical Service Product Portfolio
- 12.18.5 Creative Biolabs Recent Developments
- 12.19 Evox Therapeutics
- 12.19.1 Evox Therapeutics Company Information
- 12.19.2 Evox Therapeutics Business Overview
- 12.19.3 Evox Therapeutics Revenue in Exosome Analytical Service Business (2021-2026)
- 12.19.4 Evox Therapeutics Exosome Analytical Service Product Portfolio
- 12.19.5 Evox Therapeutics Recent Developments
- 12.20 Precision NanoSystems
- 12.20.1 Precision NanoSystems Company Information
- 12.20.2 Precision NanoSystems Business Overview
- 12.20.3 Precision NanoSystems Revenue in Exosome Analytical Service Business (2021-2026)
- 12.20.4 Precision NanoSystems Exosome Analytical Service Product Portfolio
- 12.20.5 Precision NanoSystems Recent Developments
- 12.21 Unisensor SA
- 12.21.1 Unisensor SA Company Information
- 12.21.2 Unisensor SA Business Overview
- 12.21.3 Unisensor SA Revenue in Exosome Analytical Service Business (2021-2026)
- 12.21.4 Unisensor SA Exosome Analytical Service Product Portfolio
- 12.21.5 Unisensor SA Recent Developments
- 12.22 VolitionRx Limited
- 12.22.1 VolitionRx Limited Company Information
- 12.22.2 VolitionRx Limited Business Overview
- 12.22.3 VolitionRx Limited Revenue in Exosome Analytical Service Business (2021-2026)
- 12.22.4 VolitionRx Limited Exosome Analytical Service Product Portfolio
- 12.22.5 VolitionRx Limited Recent Developments
- 12.23 Capricor Therapeutics
- 12.23.1 Capricor Therapeutics Company Information
- 12.23.2 Capricor Therapeutics Business Overview
- 12.23.3 Capricor Therapeutics Revenue in Exosome Analytical Service Business (2021-2026)
- 12.23.4 Capricor Therapeutics Exosome Analytical Service Product Portfolio
- 12.23.5 Capricor Therapeutics Recent Developments
- 12.24 Pure Biologics
- 12.24.1 Pure Biologics Company Information
- 12.24.2 Pure Biologics Business Overview
- 12.24.3 Pure Biologics Revenue in Exosome Analytical Service Business (2021-2026)
- 12.24.4 Pure Biologics Exosome Analytical Service Product Portfolio
- 12.24.5 Pure Biologics Recent Developments
- 12.25 Janssen Biotech
- 12.25.1 Janssen Biotech Company Information
- 12.25.2 Janssen Biotech Business Overview
- 12.25.3 Janssen Biotech Revenue in Exosome Analytical Service Business (2021-2026)
- 12.25.4 Janssen Biotech Exosome Analytical Service Product Portfolio
- 12.25.5 Janssen Biotech Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst